Phio Pharmaceuticals (PHIO) Assets Average (2011 - 2026)

Phio Pharmaceuticals (PHIO) has reported Assets Average for 16 consecutive years, with $15.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average rose 28.2% year-over-year to $15.9 million; the trailing twelve-month figure through Jun 2026 stood at $15.9 million (up 28.2% YoY), and the FY2025 full-year result was $13.6 million, up 80.27% from the prior year.
• Assets Average retreated to $15.9 million in Q2 2026 per PHIO's latest filing, from $19.4 million in the prior quarter.
• Across five years, Assets Average topped out at $23.7 million in Q1 2022 and bottomed at $5.6 million in Q3 2024.
• Historically, Assets Average has averaged $12.8 million across 5 years, with a median of $11.3 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Assets Average slumped 52.42% in 2023, then surged 184.34% in 2025.
• Over 5 years, Assets Average stood at $14.3 million in 2022, then slumped by 33.92% to $9.5 million in 2023, then tumbled by 38.62% to $5.8 million in 2024, then soared by 184.34% to $16.5 million in 2025, then decreased by 3.86% to $15.9 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $15.9 million, $19.4 million, and $16.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.